Therapeutic approaches to inhibit TGF-β/SMAD-induced liver fibrosis (IMAGE)
Caption
Schematic representation of different strategies targeting TGF-β signaling for liver fibrosis therapy.
TGF-β signaling inhibitors hold important therapeutic potential for hepatic fibrosis. Although many challenges remain, detailed exploration of these inhibitors, including certain natural products, is necessary to clarify their anti-fibrotic effects. In the future, effective anti-fibrotic drugs may be developed to alleviate or even reverse the progression of liver fibrosis, ushering in a new era in its pharmacological treatment.
Credit
Lingying Huang, Zhi Shang
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC